American Roentgen Ray Society: Aspirin Improves Liver Function After Embolization of Hepatocellular Carcinoma
July 31, 2019
July 31, 2019
LEESBURG, Virginia, July 31 -- The American Roentgen Ray Society issued the following news release:
Aspirin therapy is associated with both improved liver function test results and survival after transarterial embolization (TAE) for hepatocellular carcinoma (HCC), according to an ahead-of-print article published in the September 2019 issue of the American Journal of Roentgenology (AJR).
In a retrospective review of 304 patients led by F. Edward Boas at Memorial Sloan Ke . . .
Aspirin therapy is associated with both improved liver function test results and survival after transarterial embolization (TAE) for hepatocellular carcinoma (HCC), according to an ahead-of-print article published in the September 2019 issue of the American Journal of Roentgenology (AJR).
In a retrospective review of 304 patients led by F. Edward Boas at Memorial Sloan Ke . . .